oral pill glp 1 US FDA accepts Novo Nordisk's application for Wegovy for weight loss New GLP-1 Pill Foundayo (Orforglipron)

The case of the 23-year-old woman who developed alopecia areata two months after starting semaglutide demonstrates that GLP-1 medications can potentially trigger autoimmune hair loss in susceptible individuals

Neuropharmacology 86 , 241258 (2014)

Evidence from Clinical Trials Clinical trials investigating the efficacy of GLP-1 agonists have revealed promising results

If you want to lose weight, start by speaking to a primary care physician, Dr

Once weight loss is no longer the primary driver

We are committed to providing our patients with the most advanced options for managing weight, diabetes, and overall metabolic health